[PHARMA] YoY Quarter Result on 30-Jun-2010 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
11-Aug-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
30-Jun-2010 [#2]
Profit Trend
QoQ- 58.45%
YoY- -16.67%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Revenue 437,633 456,737 396,435 350,335 333,212 353,465 300,231 6.47%
PBT 9,605 27,618 19,380 20,327 24,337 21,088 12,181 -3.87%
Tax -3,434 -11,541 -5,335 -5,809 -5,814 -7,631 -4,964 -5.95%
NP 6,171 16,077 14,045 14,518 18,523 13,457 7,217 -2.57%
-
NP to SH 5,865 15,713 13,920 14,747 17,697 13,107 6,640 -2.04%
-
Tax Rate 35.75% 41.79% 27.53% 28.58% 23.89% 36.19% 40.75% -
Total Cost 431,462 440,660 382,390 335,817 314,689 340,008 293,014 6.65%
-
Net Worth 480,568 481,394 451,517 417,065 400,161 362,716 314,357 7.32%
Dividend
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Div 8,810 8,827 - 50,261 28,888 19,259 16,038 -9.49%
Div Payout % 150.22% 56.18% - 340.83% 163.24% 146.94% 241.55% -
Equity
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Net Worth 480,568 481,394 451,517 417,065 400,161 362,716 314,357 7.32%
NOSH 258,370 117,700 106,994 106,939 106,995 106,995 106,924 15.82%
Ratio Analysis
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
NP Margin 1.41% 3.52% 3.54% 4.14% 5.56% 3.81% 2.40% -
ROE 1.22% 3.26% 3.08% 3.54% 4.42% 3.61% 2.11% -
Per Share
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
RPS 169.38 388.05 370.52 327.60 311.43 330.35 280.79 -8.07%
EPS 2.27 13.35 13.01 13.79 16.54 12.25 6.21 -15.42%
DPS 3.41 7.50 0.00 47.00 27.00 18.00 15.00 -21.85%
NAPS 1.86 4.09 4.22 3.90 3.74 3.39 2.94 -7.34%
Adjusted Per Share Value based on latest NOSH - 106,939
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
RPS 30.37 31.69 27.51 24.31 23.12 24.53 20.83 6.47%
EPS 0.41 1.09 0.97 1.02 1.23 0.91 0.46 -1.89%
DPS 0.61 0.61 0.00 3.49 2.00 1.34 1.11 -9.48%
NAPS 0.3334 0.334 0.3133 0.2894 0.2777 0.2517 0.2181 7.32%
Price Multiplier on Financial Quarter End Date
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Date 28/06/13 29/06/12 30/06/11 30/06/10 30/06/09 30/06/08 29/06/07 -
Price 4.49 10.18 5.90 4.98 3.80 3.27 3.53 -
P/RPS 2.65 2.62 1.59 1.52 1.22 0.99 1.26 13.17%
P/EPS 197.80 76.25 45.35 36.11 22.97 26.69 56.84 23.07%
EY 0.51 1.31 2.21 2.77 4.35 3.75 1.76 -18.63%
DY 0.76 0.74 0.00 9.44 7.11 5.50 4.25 -24.92%
P/NAPS 2.41 2.49 1.40 1.28 1.02 0.96 1.20 12.31%
Price Multiplier on Announcement Date
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Date 16/08/13 08/08/12 10/08/11 11/08/10 21/08/09 14/08/08 17/08/07 -
Price 4.66 8.83 5.90 4.95 4.00 3.44 3.44 -
P/RPS 2.75 2.28 1.59 1.51 1.28 1.04 1.23 14.33%
P/EPS 205.29 66.14 45.35 35.90 24.18 28.08 55.39 24.37%
EY 0.49 1.51 2.21 2.79 4.14 3.56 1.81 -19.55%
DY 0.73 0.85 0.00 9.49 6.75 5.23 4.36 -25.73%
P/NAPS 2.51 2.16 1.40 1.27 1.07 1.01 1.17 13.55%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment